Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in those with type 1 diabetes in Scotland between 2004 and 2016, and whether any trends differed by sociodemographic factors.Methods: We analysed records from 30,717 people with type 1 diabetes, registered anytime between 2004 and 2016 in the national diabetes database, which contained repeated measures of HbA 1c. An additive mixed regression model was used to estimate calendar time and other effects on HbA 1c.Results: Overall, median (IQR) HbA 1c decreased from 72 (21) mmol/mol [8.7 (4.1)%] in 2004 to 68 (21) mmol/mol (8.4 [4.1]%) in 2016. However, all of the improvement across the period occurred in the latter 4 years: the regression model showed t...
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) i...
Objective: Whether advances in the management of type 1 diabetes are reducing rates of diabetic keto...
AIMS/HYPOTHESIS: Our objectives were to explore whether the phenomenon of HbA1c 'tracking' occurs in...
Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in those...
Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in thos...
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) in...
Acknowledgements We thank the SDRN Epidemiology Group: J. Chalmers (Diabetes Centre, Victoria Hospit...
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) i...
Objective: Whether advances in the management of type 1 diabetes are reducing rates of diabetic keto...
AIMS/HYPOTHESIS: Our objectives were to explore whether the phenomenon of HbA1c 'tracking' occurs in...
Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in those...
Aims/hypothesis: The aim of this work was to examine whether glycaemic control has improved in thos...
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) in...
Acknowledgements We thank the SDRN Epidemiology Group: J. Chalmers (Diabetes Centre, Victoria Hospit...
Aims/hypothesis: Our aim was to assess the use of continuous subcutaneous insulin infusion (CSII) i...
Objective: Whether advances in the management of type 1 diabetes are reducing rates of diabetic keto...
AIMS/HYPOTHESIS: Our objectives were to explore whether the phenomenon of HbA1c 'tracking' occurs in...